drugset / Trial / NCT02125227

Phase 1 Clinical Trial to Investigate the Effect on the Pharmacokinetics of YH14755 Compared to Co-administration of Rosuvastatin and Metformin SR in Healthy Volunteers

NCT02125227

Phase 1 Completed 56 enrolled Yuhan Corporation
RandomizedCrossoverOpen-label

Summary

The objective of this study is to Compare the Safety and the Pharmacokinetic Characteristics of the Co-administration of Rosuvastatin and Metformin SR and YH14755 and to Investigate the Effect of Food on the Pharmacokinetics of YH14755 in healthy volunteers.

Timeline

Start
2014-04
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule
Subject Rosuvastatin Small molecule
Subject YH14755 Unknown

Indications

No indication recorded.